World Library  

Add to Book Shelf
Flag as Inappropriate
Email this Book

Plos Genetics : the Transcription Factor Rest is Lost in Aggressive Breast Cancer, Volume 6

By Lieb, Jason D.

Click here to view

Book Id: WPLBN0003929902
Format Type: PDF eBook :
File Size:
Reproduction Date: 2015

Title: Plos Genetics : the Transcription Factor Rest is Lost in Aggressive Breast Cancer, Volume 6  
Author: Lieb, Jason D.
Volume: Volume 6
Language: English
Subject: Journals, Science, Genetics
Collections: Periodicals: Journal and Magazine Collection, PLoS Genetics
Publication Date:
Publisher: Plos


APA MLA Chicago

Lieb, J. D. (n.d.). Plos Genetics : the Transcription Factor Rest is Lost in Aggressive Breast Cancer, Volume 6. Retrieved from

Description : The function of the tumor suppressor RE1 silencing transcription factor (REST) is lost in colon and small cell lung cancers and is known to induce anchorage-independent growth in human mammary epithelial cells. However, nothing is currently known about the role of this tumor suppressor in breast cancer. Here, we test the hypothesis that loss of REST function plays a role in breast cancer. To assay breast tumors for REST function, we developed a 24-gene signature composed of direct targets of the transcriptional repressor. Using the 24- gene signature, we identified a previously undefined RESTless breast tumor subtype. Using gene set enrichment analysis, we confirmed the aberrant expression of REST target genes in the REST–less tumors, including neuronal gene targets of REST that are normally not expressed outside the nervous system. Examination of REST mRNA identified a truncated splice variant of REST present in the REST–less tumor population, but not other tumors. Histological analysis of 182 outcome-associated breast tumor tissues also identified a subpopulation of tumors that lack full-length, functional REST and over-express the neuroendocrine marker and REST target gene Chromogranin A. Importantly, patients whose tumors were found to be REST–less using either the 24-gene signature or histology had significantly poorer prognosis and were more than twice as likely to undergo disease recurrence within the first 3 years after diagnosis. We show here that REST function is lost in breast cancer, at least in part via an alternative splicing mechanism. Patients with REST–less breast cancer undergo significantly more early disease recurrence than those with fully functional REST, regardless of estrogen receptor or HER2 status. Importantly, REST status may serve as a predictor of poor prognosis, helping to untangle the heterogeneity inherent in disease course and response to treatment. Additionally, the alternative splicing observed in REST–less breast cancer is an attractive therapeutic target.


Click To View

Additional Books

  • Plos Genetics : Evolutionary Conserved R... (by )
  • Plos Genetics : Bias and Evolution of th... (by )
  • Plos Genetics : Systematic Identificatio... (by )
  • Plos Genetics : Chd7 Targets Active Gene... (by )
  • Plos Genetics : Tdp2–dependent Non-homol... (by )
  • Plos Genetics : Ataxin1L is a Regulator ... (by )
  • Plos Genetics : Epigenetic Regulation of... (by )
  • Plos Genetics : Field-caught Permethrin-... (by )
  • Plos Genetics : Chromatin Sampling—an Em... (by )
  • Plos Genetics : Copy Number Variation of... (by )
  • Plos Genetics : Matrilineal Fertility In... (by )
  • Plos Genetics : Mutransposon Insertion S... (by )
Scroll Left
Scroll Right


Copyright © World Library Foundation. All rights reserved. eBooks from National Public Library are sponsored by the World Library Foundation,
a 501c(4) Member's Support Non-Profit Organization, and is NOT affiliated with any governmental agency or department.